Although the expression of TNFα & IL-1β receptors by breast tumor cells was already documented [29,31,37,43,44], it is possible that in this specific sub-group of the IDC-with-recurrence patients, the tumor cells do not express the required receptors for TNFα & IL-1β, or express non-signaling receptors. Here, TNF is linked to neoplasm.